Buds & Duds: Cannabis stocks lackluster heading into weekend; HEXO files financial statements

Most major cannabis stocks found themselves in the red on Friday morning

cannabis arrow
It was a quiet start to the year for most cannabis companies

Cannabis stocks sank to end the trading week across North America. 

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, fell 1.4% at 118.9 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF lost 0.6% at C$8.52, while the OTCQX Cannabis index retreated 1.7% to 460.5 points. 


CannaRoyalty Corp, which conducts business as Origin House (CSE:OH) (OTCMKTS:ORHOF) announced earlier this week that its acquisition of Cresco Labs Inc (CSE:CL) took another step forward after Origin House shareholders gave their approval for the deal. 

The acquisition will create one of the largest vertically integrated multi-state cannabis operators in the United States, according to Origin House’s CEO Marc Lustig. The deal was first announced last April. 

Shares of Origin House were trading flat on Friday but have gained nearly 47% over the last month. 

Small cap stock Weekend Unlimited Inc (CSE:POT) (OTCMKTS:WKULF) was having a good Friday, up 25% in Canada on news that it is planning to move its headquarters from Alberta to British Columbia. Its shares reached C$0.03. 


Most major cannabis stocks found themselves in the red on Friday morning. 

HEXO Corp (TSE:HEXO) (NYSE:HEXO), which just refiled its financial statements, was trading down 4.7% in Toronto and 4% in New York at C$2.04 and US$1.58 respectively.  

Others trending downwards included Sundial Growers Inc (NASDAQ:SNDL), down 5% at US$2.88, and Cronos Group Inc (TSE:CRON) (NASDAQ), which lost 3% in Toronto at C$9.26 and 3.1% in New York at US$7.13. 

Contact Angela at [email protected] 

Follow her on Twitter @AHarmantas 

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Symphony Environmental Technologies has game changing...

Symphony Environmental Technologies PLC (AIM: SYM) CEO Michael Laurier joined Steve Darling from Proactive with news the company has received U.S. Food & Drugs Administration approval or its d2p antimicrobial technology. Laurier discusses what that means for the company and what their...

20 hours, 44 minutes ago

2 min read